Bianka Prinz

Person

Lebanon, NH, US

People

Patents Grantslast 30 patents

Information Patent Grant
Multi-specific binding proteins that bind CD33, NKG2D, and CD16, an...
- Patent number 12,215,157
- Issue date Feb 4, 2025
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dual specificity antibodies to PD-L1 and PD-L2 and methods of use t...
- Patent number 12,187,799
- Issue date Jan 7, 2025
- Board of Regents, The University of Texas System
- Michael A. Curran
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CD38 antibody
- Patent number 12,162,949
- Issue date Dec 10, 2024
- BLACK BELT THERAPEUTICS LIMITED
- Anne Goubier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD38 modulating antibody agents
- Patent number 12,161,717
- Issue date Dec 10, 2024
- BLACK BELT THERAPEUTICS LIMITED
- Pascal Merchiers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dual specificity antibodies to human PD-L1 and PD-L2 and methods of...
- Patent number 12,134,648
- Issue date Nov 5, 2024
- Board of Regents, The University of Texas System
- Michael A. Curran
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody variable domains targeting the NKG2D receptor
- Patent number 12,129,300
- Issue date Oct 29, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Surface display of whole antibodies in eukaryotes
- Patent number 12,084,651
- Issue date Sep 10, 2024
- Merck Sharp & Dohme LLC
- Bianka Prinz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-CD19 antibodies and uses therof
- Patent number 12,049,499
- Issue date Jul 30, 2024
- Millennium Pharmaceuticals, Inc.
- Daniel Tavares
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human PD-L2 antibodies and methods of use therefor
- Patent number 11,976,128
- Issue date May 7, 2024
- Board of Regents, The University of Texas System
- Michael A. Curran
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody variable domains targeting the NKG2D receptor
- Patent number 11,939,384
- Issue date Mar 26, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody variable domains targeting the NKG2D receptor
- Patent number 11,884,733
- Issue date Jan 30, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Proteins binding HER2, NKG2D and CD16
- Patent number 11,884,732
- Issue date Jan 30, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD25 for tumour specific cell depletion
- Patent number 11,814,434
- Issue date Nov 14, 2023
- Tusk Therapeutics Ltd.
- Anne Goubier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD25 antibody agents
- Patent number 11,802,160
- Issue date Oct 31, 2023
- Tusk Therapeutics Ltd.
- Anne Goubier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD25 for tumour specific cell depletion
- Patent number 11,802,161
- Issue date Oct 31, 2023
- Tusk Therapeutics Ltd.
- Anne Goubier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD25 antibody agents
- Patent number 11,787,866
- Issue date Oct 17, 2023
- Tusk Therapeutics Ltd.
- Anne Goubier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CD38 modulating antibody
- Patent number 11,780,930
- Issue date Oct 10, 2023
- BLACK BELT THERAPEUTICS LIMITED
- Pascal Merchiers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD25 for tumour specific cell depletion
- Patent number 11,697,688
- Issue date Jul 11, 2023
- Tusk Therapeutics Ltd.
- Anne Goubier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-coagulation factor XI antibodies
- Patent number 11,661,460
- Issue date May 30, 2023
- Merck Sharp & Dohme LLC
- Zhu Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD39 antibody compositions and methods
- Patent number 11,655,303
- Issue date May 23, 2023
- Surface Oncology, Inc.
- Scott Chappel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD38 modulating antibody
- Patent number 11,542,338
- Issue date Jan 3, 2023
- BLACK BELT THERAPEUTICS LIMITED
- Anne Goubier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human PD-L1 antibodies and methods of use therefor
- Patent number 11,525,002
- Issue date Dec 13, 2022
- Board of Regents, The University of Texas System
- Michael A. Curran
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoclonal antibodies against HER2 epitope and methods of use thereof
- Patent number 11,518,812
- Issue date Dec 6, 2022
- Mersana Therapeutics, Inc.
- Natalya D. Bodyak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-coagulation factor XI antibodies
- Patent number 11,512,142
- Issue date Nov 29, 2022
- Merck Sharp & Dohme LLC
- Zhu Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-coagulation factor XI antibodies
- Patent number 11,485,794
- Issue date Nov 1, 2022
- Merck Sharp & Dohme LLC
- Zhu Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-coagulation factor XI antibodies
- Patent number 11,479,615
- Issue date Oct 25, 2022
- Merck Sharp & Dohme LLC
- Zhu Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-TIGIT antibodies
- Patent number 11,401,339
- Issue date Aug 2, 2022
- SEAGEN INC.
- Julia C. Piasecki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-IL-27 antibodies and uses thereof
- Patent number 11,332,524
- Issue date May 17, 2022
- Surface Oncology, Inc.
- Jonathan Hill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to CD73 and uses thereof
- Patent number 11,312,783
- Issue date Apr 26, 2022
- Novartis AG
- Bianka Prinz
- G01 - MEASURING TESTING
Information Patent Grant
Anti-CD112R compositions and methods
- Patent number 11,279,758
- Issue date Mar 22, 2022
- Surface Oncology, Inc.
- Bianka Prinz
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20250019444
- Publication date Jan 16, 2025
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD19 ANTIBODIES AND USES THEROF
- Publication number 20240400676
- Publication date Dec 5, 2024
- Millennium Pharmaceuticals, Inc.
- Daniel Tavares
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD25 ANTIBODY AGENTS
- Publication number 20240309101
- Publication date Sep 19, 2024
- Tusk Therapeutics Ltd.
- Anne Goubier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HUMAN PD-L2 ANTIBODIES AND METHODS OF USE THEREFOR
- Publication number 20240270867
- Publication date Aug 15, 2024
- Board of Regents, The University of Texas System
- Michael A. CURRAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING HER2, NKG2D AND CD16
- Publication number 20240228625
- Publication date Jul 11, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD38 MODULATING ANTIBODY
- Publication number 20240092928
- Publication date Mar 21, 2024
- BLACK BELT THERAPEUTICS LIMITED
- Pascal Merchiers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20240076385
- Publication date Mar 7, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20240076384
- Publication date Mar 7, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20240067735
- Publication date Feb 29, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN PD-L1 ANTIBODIES AND METHODS OF USE THEREFOR
- Publication number 20240043538
- Publication date Feb 8, 2024
- Board of Regents, The University of Texas System
- Michael A. CURRAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEINS BINDING CD123, NKG2D AND CD16
- Publication number 20240018266
- Publication date Jan 18, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC BINDING PROTEINS TARGETING CEA
- Publication number 20230391877
- Publication date Dec 7, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND NECTIN4
- Publication number 20230357409
- Publication date Nov 9, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...
- Publication number 20230303702
- Publication date Sep 28, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-COAGULATION FACTOR XI ANTIBODIES
- Publication number 20230287141
- Publication date Sep 14, 2023
- Merck Sharp & Dohme LLC
- Zhu Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF
- Publication number 20230265197
- Publication date Aug 24, 2023
- MERSANA THERAPEUTICS, INC.
- Natalya D. BODYAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...
- Publication number 20230227562
- Publication date Jul 20, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN PD-L2 ANTIBODIES AND METHODS OF USE THEREFOR
- Publication number 20230174661
- Publication date Jun 8, 2023
- Board of Regents, The University of Texas System
- Michael A. CURRAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-TIGIT Antibodies
- Publication number 20230134375
- Publication date May 4, 2023
- Seagen Inc.
- Julia C. Piasecki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD38 MODULATING ANTIBODY AGENTS
- Publication number 20230103584
- Publication date Apr 6, 2023
- BLACK BELT THERAPEUTICS LIMITED
- Pascal Merchiers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD38 MODULATING ANTIBODY
- Publication number 20230089373
- Publication date Mar 23, 2023
- BLACK BELT THERAPEUTICS LIMITED
- Anne Goubier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Anti-TIGIT Antibodies
- Publication number 20230050440
- Publication date Feb 16, 2023
- Seagen Inc.
- Julia C. Piasecki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-IL-27 ANTIBODIES AND USES THEREOF
- Publication number 20230042258
- Publication date Feb 9, 2023
- Surface Oncology, Inc.
- Jonathan HILL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD19 ANTIBODIES AND MULTI-SPECIFIC BINDING PROTEINS
- Publication number 20230037815
- Publication date Feb 9, 2023
- Cullinan Oncology, Inc.
- Patrick A. Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO CD73 AND USES THEREOF
- Publication number 20230039109
- Publication date Feb 9, 2023
- Novartis AG
- Bianka Prinz
- G01 - MEASURING TESTING
Information Patent Application
ANTI-SERUM ALBUMIN ANTIBODIES
- Publication number 20230032087
- Publication date Feb 2, 2023
- Cullinan Oncology, Inc.
- Patrick A. Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED PH-DEPENDENT ANTI-CD3 ANTIBODIES, AND METHODS FOR THEIR...
- Publication number 20220380463
- Publication date Dec 1, 2022
- ADIMAB, LLC
- James GEOGHEGAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AN...
- Publication number 20220380459
- Publication date Dec 1, 2022
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-CD39 Antibody Compositions and Methods
- Publication number 20220372160
- Publication date Nov 24, 2022
- Surface Oncology, Inc.
- Scott CHAPPEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-IL-27 ANTIBODIES AND USES THEREOF
- Publication number 20220259299
- Publication date Aug 18, 2022
- Surface Oncology, Inc.
- Jonathan HILL
- C07 - ORGANIC CHEMISTRY

Bianka Prinz

Person

Patents Grantslast 30 patents

Multi-specific binding proteins that bind CD33, NKG2D, and CD16, an...

Dual specificity antibodies to PD-L1 and PD-L2 and methods of use t...

CD38 antibody

CD38 modulating antibody agents

Dual specificity antibodies to human PD-L1 and PD-L2 and methods of...

Antibody variable domains targeting the NKG2D receptor

Surface display of whole antibodies in eukaryotes

Anti-CD19 antibodies and uses therof

Human PD-L2 antibodies and methods of use therefor

Antibody variable domains targeting the NKG2D receptor

Antibody variable domains targeting the NKG2D receptor

Proteins binding HER2, NKG2D and CD16

Anti-CD25 for tumour specific cell depletion

Anti-CD25 antibody agents

Anti-CD25 for tumour specific cell depletion

Anti-CD25 antibody agents

CD38 modulating antibody

Anti-CD25 for tumour specific cell depletion

Anti-coagulation factor XI antibodies

Anti-CD39 antibody compositions and methods

CD38 modulating antibody

Human PD-L1 antibodies and methods of use therefor

Monoclonal antibodies against HER2 epitope and methods of use thereof

Anti-coagulation factor XI antibodies

Anti-coagulation factor XI antibodies

Anti-coagulation factor XI antibodies

Anti-TIGIT antibodies

Anti-IL-27 antibodies and uses thereof

Antibody molecules to CD73 and uses thereof

Anti-CD112R compositions and methods

Patents Applicationslast 30 patents

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

ANTI-CD19 ANTIBODIES AND USES THEROF

ANTI-CD25 ANTIBODY AGENTS

HUMAN PD-L2 ANTIBODIES AND METHODS OF USE THEREFOR

PROTEINS BINDING HER2, NKG2D AND CD16

CD38 MODULATING ANTIBODY

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

HUMAN PD-L1 ANTIBODIES AND METHODS OF USE THEREFOR

PROTEINS BINDING CD123, NKG2D AND CD16

MULTISPECIFIC BINDING PROTEINS TARGETING CEA

PROTEINS BINDING NKG2D, CD16 AND NECTIN4

COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...

ANTI-COAGULATION FACTOR XI ANTIBODIES

MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF

COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...

HUMAN PD-L2 ANTIBODIES AND METHODS OF USE THEREFOR

Anti-TIGIT Antibodies

CD38 MODULATING ANTIBODY AGENTS

CD38 MODULATING ANTIBODY

Anti-TIGIT Antibodies

ANTI-IL-27 ANTIBODIES AND USES THEREOF

ANTI-CD19 ANTIBODIES AND MULTI-SPECIFIC BINDING PROTEINS

ANTIBODY MOLECULES TO CD73 AND USES THEREOF

ANTI-SERUM ALBUMIN ANTIBODIES

ENGINEERED PH-DEPENDENT ANTI-CD3 ANTIBODIES, AND METHODS FOR THEIR...

MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AN...

Anti-CD39 Antibody Compositions and Methods

ANTI-IL-27 ANTIBODIES AND USES THEREOF